Atlas Trials

Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration

Clinical trial NCT01184820 · COMPLETED

Trial details

NCT number
NCT01184820
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemophilia A
Start date
2010-10-13
Primary completion
2011-10-10
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.